Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms
  • Receptor, ErbB-2

abstract

  • Women with small, node-negative, HER2+ primary breast cancers likely derive significant benefit from adjuvant trastuzumab with chemotherapy.

publication date

  • December 15, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.26171

PubMed ID

  • 21681735

Additional Document Info

start page

  • 5461

end page

  • 8

volume

  • 117

number

  • 24